1 Pietri E,Conteduca V,Andreis D,et al.Androgen receptor signaling pathways as a target for breast cancer treatment[J].Endocr Relat Cancer,2016,23(10):485-498. 2 Tang D,Xu S,Zhang Q,et al.The expression and clinical significance of the androgen receptor and E-cadherin in triple-negative breast cancer[J].Med Oncol,2012,29(2):526-533. 3 Liang YJ,Wang QY,Zhou CX,et al.MiR-124 targets Slug to regulate epithelial-mesenchymal transition and metastasis of breast cancer[J].Carcinogenesis,2013,34(3):713-722. 4 Shi XB,Xue L,Ma AH,et al.Tumor suppressive miR-124 targets androgen receptor and inhibits proliferation of prostate cancer cells[J].Oncogene,2013,32(35):4130-4138. 5 Luo X,Shi YX,Li ZM,et al.Expression and clinical significance of androgen receptor in triple negative breast cancer[J].Chin J Cancer,2010,29(6):585-590. 6 Kashiwagi S,Yashiro M,Takashima T,et al.Advantages of adjuvant chemotherapy for patients with triple-negative breast cancer at stage II:usefulness of prognostic markers E-cadherin and Ki67[J].Breast Cancer Res,2011,13(6):122. 7 Lehmann BD,Jovanovic B,Xi C,et al.Refinement of triple-negative breast cancer molecular subtypes:implications for neoadjuvant chemotherapy selection[J].PLoS One,2016,11(6):e0157368. 8 Sutton LM,Cao D,Sarode V,et al.Decreased androgen receptor expression is associated with distant metastases in patients with androgen receptor-expressing triple-negative breast carcinoma[J].Am J Clin Pathol,2012,138(4):511-516. 9 Gasparini P,Fassan M,Cascione L,et al.Androgen receptor status is a prognostic marker in non-basal triple negative breast cancers and determines novel therapeutic options[J].PLoS One,2014,9(2):e88525. 10 Nakagawa M,Bando Y,Nagao T,et al.Expression of p53,Ki-67,E-cadherin,N-cadherin and TOP2A in triple-negative breast cancer[J].Anticancer Res,2011,31(6):2389-2393. 11 Kashiwagi S,Yashiro M,Takashima T,et al.Significance of E-cadherin expression in triple-negative breast cancer[J].Br J Cancer,2010,103(2):249-255. 12 Quiros RM,Rao G,Plate J,et al.Elevated serum heparanase-1 levels in patients with pancreatic carcinoma are associated with poor survival[J].Cancer,2006,106(3):532-540. 13 Lv XB,Jiao Y,Qing Y,et al.miR-124 suppresses multiple steps of breast cancer metastasis by targeting a cohort of pro-metastatic genes in vitro[J].Chin J Cancer,2011,30(12):821-830. 14 Uhlmann S,Mannsperger H,Zhang JD,et al.Global microRNA level regulation of EGFR-driven cell-cycle protein network in breast cancer[J].Mol Syst Biol,2012,8:570. 15 Van Kouwenhove M,Kedde M,Agami R.MicroRNA regulation by RNA-binding proteins and its implications for cancer[J].Nat Rev Cancer 2011,11(9):644-656. 16 Siegel R,Naishadham D,Jemal A.Cancer statistics,2012[J].CA Cancer J Clin,2012,62(1):10-29. 17 O′Day E,Lal A.MicroRNAs and their target gene networks in breast cancer[J].Breast Cancer Res,2010,12(2):201. 18 Lewis BP,Burge CB,Bartel DP.Conserved seed pairing,often flanked by adenosines,indicates that thousands of human genes are microRNA targets[J].Cell,2005,120(1):15-20. 19 Melo SA,Esteller M.Dysregulation of microRNAs in cancer:playing with fire[J].FEBS Lett,2011,585(13):2087-2099. |